Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-0131|65|8|1953-1962

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.65, Iss.8, 2013-08, pp. : 1953-1962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeting Vascular Disease in Systemic Sclerosis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 401-407

Bentham Science Publishers

Access to resources Recommend Favorite

The role of infectious agents in pulmonary and systemic vascular disease

By Egermayer Paul  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1093-1097

Informa Healthcare

Access to resources Recommend Favorite

Interstitial Lung Disease in Systemic Sclerosis: Pathophysiology, Current and New Advances in Therapy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 266-277

Bentham Science Publishers

Access to resources Recommend Favorite

Bosentan: A Review of its Use in Pulmonary Arterial Hypertension and Systemic Sclerosis

By Oldfield Vicki   Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 189-208

Adis International

Access to resources Recommend Favorite

Bosentan: A Review of its Use in the Management of Digital Ulcers Associated with Systemic Sclerosis

By Dhillon Sohita  

Drugs, Vol. 69, Iss. 14, 2009-10 ,pp. : 2005-2024

Adis International

Access to resources Recommend Favorite